Thyme Care Triples Its Multidisciplinary Care Team with Increased Focus on Often-Overlooked Survivorship Population

• Oncologist Dr. Asma Dilawari and palliative care physician Dr. Nelia Jain join to expand survivorship program and scale supportive care and palliative care services

• Expansion coincides with new patient-centered supportive care offerings, including enhanced social work, emotional support, and advanced social needs planning to provide continuous support across the entire cancer journey, from pre-diagnosis through survivorship or end-of-life care   

• Rapid growth with commercial and Medicare Advantage health plans drives care team expansion across all roles, including medical directors, nurse practitioners, oncology nurses, social workers, and navigators

NASHVILLE—June 1, 2025—Thyme Care, the leading value-based cancer care enabler, today announced a significant expansion of its survivorship program and comprehensive cancer care services with the appointment of two experienced medical directors: Dr. Asma Dilawari as medical director of oncology care, who will lead the company’s survivorship program expansion, and Dr. Nelia Jain as medical director of palliative care, who will scale Thyme Care’s virtual palliative care offering, called Enhanced Supportive Care. Drs. Dilawari and Jain join Thyme Care from the FDA and Devoted Health, respectively, with previous roles held at Georgetown University and the Dana-Farber Cancer Institute and Brigham and Women's Hospital.  

Survivorship Support For Clinical, Emotional, and Nutritional Needs Beyond Oncology Care

More than 18 million cancer survivors live in the U.S. today, and that number continues to grow as new therapeutics and treatment options lead people to live longer lives. Although survivorship is often a celebratory milestone, it doesn’t mean their healthcare support should stop. Many patients continue to manage long-term side effects and emotional distress while continuing to take medications that reduce the risk of cancer recurrence, all while trying to return to work, care for their families, and navigate life after treatment. As someone who deeply understands this patient population, Dr. Dilawari will lead the expansion of Thyme Care’s survivorship program to close the critical gaps survivors face. 

“With over 15 years of experience guiding oncology patients through survivorship, I’m excited to bring these insights to Thyme Care to design systems of support as they enter a new chapter of their care,” said Dr. Dilawari. “These patients aren’t in active treatment but still may require clinical, emotional, and nutritional guidance that often isn’t adequately addressed. At Thyme Care, we want to meet these patients exactly where they are, with personalized care plans grounded in evidence-based guidelines and tailored to each survivor’s health goals and needs.” 

At Thyme Care, Dr. Dilawari will support patients in survivorship, continue to advance the company’s Electronic Patient-Reported Outcomes (ePROs) program, and collaborate with Thyme Care Oncology Partners. She joins the company from the U.S. Food and Drug Administration, where she served as a medical officer in the division of oncology. With over two decades of experience, including roles at Georgetown University and MedStar hospitals supporting survivorship patients, Dr. Dilawari brings regulatory insight and clinical expertise that will reinforce Thyme Care’s ability to navigate the evolving oncology landscape. 

Multidisciplinary Support Across the Entire Cancer Journey 

Dr. Jain’s focus will be to scale Thyme Care’s palliative care program, called Enhanced Supportive Care, so that patients have support at every stage of their journey—from early detection through active treatment and into survivorship or end-of-life care. 

Dr. Jain, formerly the physician lead of complex care at Devoted Health, brings specialized expertise in palliative care and will lead Thyme Care’s clinical team in caring for members with serious illness. She previously served as medical director of HeartPal, a palliative care service dedicated to the advancement of palliative care among patients living with advanced heart disease, at Dana-Farber Cancer Institute and Brigham and Women's Hospital. At Thyme Care, Dr. Jain will see members for palliative care outpatient appointments, oversee interdisciplinary case conferences, and help scale Thyme Care’s Enhanced Supportive Care program. 

“Thyme Care’s commitment to addressing the whole person, not just their medical diagnosis, is what excites me most about joining the company,” said Dr. Jain. “Their approach to patient-centered care aligns perfectly with my experience supporting patients with symptom management and complex decision-making across their illness trajectory. I look forward to expanding our palliative care offering across the nation and supporting our clinical team with education and resources to best support our members.” 

Thyme Care has also expanded its emotional support services and advanced social needs assistance with the addition of Stephanie Broadnax Broussard, DSW, LCSW-S, APHSW-C, and a growing team of oncology social workers. Thyme Care recognizes that oncology social workers possess specialized expertise in cancer care, including the psychosocial, emotional, and practical impacts of the disease, its treatment, and the survivorship experience. Thyme Care’s social workers are part of Thyme Care’s virtual Care Team, consisting of nurse practitioners, oncology nurses, and healthcare navigators, who are closely integrated with the treating oncologist to provide total wraparound care, whether at the clinic, home, or elsewhere. This collaborative approach ensures patients receive coordinated support regardless of location or care setting. 

“Managing a cancer diagnosis requires more care than what our current system can offer. Our Care Team expansion reflects our commitment to supporting people with cancer in every aspect of their lives, not just their medical diagnosis. And with all the changes happening in our healthcare system, delivering coordinated, patient-first care is more important than ever before,” said Dr. Julia Frydman, senior medical director who oversees the clinical team. “The additions of Dr. Dilawari, Dr. Jain, and Stephanie Broussard strengthen our ability to address the complex needs of our members and make a real impact on their cancer journey.”

About Thyme Care 

Thyme Care is the leading value-based care enabler, collaborating with payers and providers to transform the experience and outcomes for individuals living with cancer. The company partners with health plans, employers and risk-bearing providers to assume accountability for enhanced care quality, improved health outcomes, and reduced total cost of care. Thyme Care's approach combines a technology-enabled Care Team and seamless integration with more than 800 oncologists in Thyme Care Oncology Partners, creating a hybrid collaborative care model that guides and supports the entire patient journey. Thyme Care empowers oncologists nationwide through purpose-built tech, advanced data analytics, and virtual patient engagement, driving better care and outcomes in value-based arrangements. Thyme Care is a founding member of CancerX, and is backed by leading investors. To learn more about how Thyme Care is enabling the shift to value-based care in oncology, visit www.thymecare.com.

Contact

Kimberly Dreisinger 

Thyme Care Communications 

press@thymecare.com